Abstract:Background: The persistence of antibiotic resistance has incited a strong interest in the discovery of agents with novel antimicrobial mechanisms. The direct killing of multidrug-resistant bacteria by cationic antimicrobial peptides (AMPs) underscores their importance in the fight against infections associated with antibiotic resistance. Despite a vast body of AMP literature demonstrating a plurality in structural classes, AMP engineering has been largely skewed toward peptides with idealized amphipathic helices (H-amphipathic). In contrast to helical amphipathicity, we designed a series of peptides that display the amphipathic motifs in the primary structure. We previously developed a rational framework for designing AMP libraries of H-amphipathic peptides consisting of Arg, Trp, and Val (H-RWV, with a confirmed helicity up to 88% in the presence of membrane lipids) tested against the most common MDR organisms. Methods: In this study, we re-engineered one of the series of the H-RWV peptides (8, 10, 12, 14, and 16 residues in length) to display the amphipathicity in the primary structure by side-by-side (linear) alignment of the cationic and hydrophobic residues into the 2 separate linear amphipathic (L-amphipathic) motifs. We compared the 2 series of peptides for antibacterial activity, red blood cell (RBC) lysis, killing and membrane-perturbation properties. Results: The L-RWV peptides achieved the highest antibacterial activity at a minimum length of 12 residues (L-RWV12, minimum optimal length or MOL) with the lowest mean MIC of 3–4 μM, whereas the MOL for the H-RWV series was reached at 16 residues (H-RWV16). Overall, H-RWV16 displayed the lowest mean MIC at 2 μM but higher levels of RBC lysis (25–30%), while the L-RWV series displayed minor RBC lytic effects at the test concentrations. Interestingly, when the S. aureus strain SA719 was chosen because of its susceptibility to most of the peptides, none of the L-RWV peptides demonstrated a high level of membrane perturbation determined by propidium iodide incorporation measured by flow cytometry, with <50% PI incorporation for the L-RWV peptides. By contrast, most H-RWV peptides displayed almost up to 100% PI incorporation. The results suggest that membrane perturbation is not the primary killing mechanism of the L-amphipathic RWV peptides, in contrast to the H-RWV peptides. Conclusions: Taken together, the data indicate that both types of amphipathicity may provide different ideal pharmacological properties that deserve further investigation.

Amphipathicity Determines Different Cytotoxic Mechanisms of Lysine- or Arginine-Rich Cationic Hydrophobic Peptides in Cancer Cells.

Pro-apoptotic Cationic Host Defense Peptides Rich in Lysine or Arginine to Reverse Drug Resistance by Disrupting Tumor Cell Membrane.

Rationally Designed Short Cationic Α-Helical Peptides with Selective Anticancer Activity.

Toggling Preassembly with Single-Site Mutation Switches the Cytotoxic Mechanism of Cationic Amphipathic Peptides

New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells

Hydrophobicity-tuned anion responsiveness underlies endosomolytic cargo delivery mediated by amphipathic vehicle peptides

One New Acid-Activated Hybrid Anticancer Peptide by Coupling with a Desirable Ph-Sensitive Anionic Partner Peptide.

Exploring Structure-Directed Immunogenic Cytotoxicity of Arginine-Rich Peptides for Cytolysis-Induced Immunotherapy of Cancer

Effect of Hydrophobicity on Distinct Anticancer Mechanism of Antimicrobial Peptide Chensinin-1B and Its Lipoanalog PA-C1b in Breast Cancer Cells

Constructing New Acid-Activated Anticancer Peptide by Attaching a Desirable Anionic Binding Partner Peptide.

Cell surface binding, uptaking and anticancer activity of L-K6, a lysine/leucine-rich peptide, on human breast cancer MCF-7 cells

A Lipid-Sensitive Spider Peptide Toxin Exhibits Selective Anti-Leukemia Efficacy through Multimodal Mechanisms

Dual modes of antitumor action of an amphiphilic peptide A9K

Correlation Between the Secondary Structure and Surface Activity of Β-Sheet Forming Cationic Amphiphilic Peptides and Their Anticancer Activity.

Novel Peptide Myristoly-Cm4 Induces Selective Cytotoxicity in Leukemia K562/MDR and Jurkat Cells by Necrosis And/or Apoptosis Pathway

Development of a Lytic Peptide Derived from BH3-only Proteins

Disruption of Tumor Cells Using a Ph-Activated and Thermosensitive Antitumor Lipopeptide Containing a Leucine Zipper Structure

Surface Physical Activity and Hydrophobicity of Designed Helical Peptide Amphiphiles Control Their Bioactivity and Cell Selectivity.

Comparative Properties of Helical and Linear Amphipathicity of Peptides Composed of Arginine, Tryptophan, and Valine

Smart and selective cancer-killing peptides with cell penetrating sequence and dual-targeting mechanism

Construction of cationic amphipathic peptide-lipid nanoparticle and evaluation of its cytotoxicity and stability in vitro